FDA, industry preaching opposing CBD narratives on Capitol Hill
Lawmakers on Capitol Hill are hearing starkly different messages from FDA and hemp industry stakeholders on the safety profile of cannabidiol (CBD).
Source: naturalproductsinsider.com
Page 2 - Patrick Cournoyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Cournoyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Cournoyer Today - Breaking & Trending Today
Industry groups: FDA harm-reduction framework threatens DSHEA
Dietary supplement trade groups contend a "harm-reduction” framework for CBD envisioned by FDA would undermine the law applicable to the commodity.
Source: naturalproductsinsider.com
CBD stakeholder's call: "It's really in Congress' hands"
With the ongoing theme of safety, FDA recently addressed CBD. While offering up several potential scenarios, the Agency said the CBD marketplace ultimately rests in the hands of Congress.
Source: nutraingredients-usa.com
FDA: Little known about 'risk profile' of synthetic cannabinoids
An FDA official last week reiterated concerns over the potential risks of synthetic cannabinoids, including delta-8 THC.
Source: naturalproductsinsider.com
FDA official outlines 'harm-reduction' framework for CBD | Natural Products INSIDER
FDA envisions a pathway for CBD in food and dietary supplements that reduces harm while helping consumers make informed decisions regarding their health.
Source: naturalproductsinsider.com